Skip to main content

Beat the rush! Make sure to use your benefits before they expire at the end of the year.

As part of our COVID-19 protocol we are now requiring our patients to undergo an Optomap Retinal exam in lieu of dilation to evaluate the inside lining of the eye. This procedure is being performed to lessen the time spent in our office. There is an additional fee of $35.00 for this test which is often not covered by insurance plans as it is considered a health screening. However, it can be billed to a medical insurance plan if there is a retinal disease diagnosis. Please speak to our staff for more information.

dr.Warstadt Logo

Anniversary WhiteEmblem Transparent

Overview

Macular degeneration (also called AMD, ARMD, or age-related macular degeneration) is an age-related condition in which the most sensitive part of the retina, called the macula, starts to break down and lose its ability to create clear visual images. The macula is responsible for central vision – the part of our sight we use to read, drive and recognize faces. So although a person's peripheral vision is left unaffected by AMD, the most important aspect of vision is lost.

AMD is the leading cause of vision loss and blindness in Americans of ages 65 and older. And because older people represent an increasingly larger percentage of the general population, vision loss associated with macular degeneration is a growing problem.

It's estimated that more than 1.75 million U.S. residents currently have significant vision loss from AMD, and that number is expected to grow to almost 3 million by 2020.